MedPath

Evaluating Quebec's Red-Cross Intervention

Not Applicable
Completed
Conditions
Aging
Social Isolation
Interventions
Other: Recommendations and re-orientation towards appropriate physical, mental, and social health ressources
Registration Number
NCT05099042
Lead Sponsor
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
Brief Summary

With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 to 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) concludes that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs.

Thus the principal investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital platform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. The principal investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable.

Hence, the principal investigator hypothesizes that ESOGER is a clinical tool enabling first line care by the Red-Cross to vulnerable EP without a family doctor, which will lead to an improvement in their health, autonomy and quality of life. Moreover, the principal investigator also hypothesizes that for a better deployment, the tool needs to be adapted to Red-Cross' need and EP service providers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Aged 65 and more
  • Living at home
  • Be registered at the waiting list of GACO at the CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL)
Exclusion Criteria
  • Principal address outside of the CCSMTL territory
  • Participate at another clinical trial, to avoid interferences
  • Not understand written or spoken French or English, questionnaires are only available in French and English.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group intervention - questionnaire and recommendationsRecommendations and re-orientation towards appropriate physical, mental, and social health ressourcesThe intervention group will take the ESOGER questionnaire at month 0 and month 3 ( beginning and end) and receive recommendations following their needs.
Primary Outcome Measures
NameTimeMethod
Socio-economic characteristics3 months

Presence or not of socio-economic problems (binary questions)

Autonomy3 months

ADL scale score from 0= very dependent to 6= very independent and IADL scale score 0= not autonomous 4= autonomous.

COVID-19 symptoms assessed through a questionnaire3 months

presence or not of fever, cough, and shortness of breath (binary question)

Participant's Quality of life3 months

Measured by the EQ-5D scale with two parts, scale 1 score from 1= no problem to 5 ( sever health problems) and scale 2 visual analogic scale score from 0= worst possible health to 100= best possible health.

Social health measured through a questionnaire3 months

Issues related to medication and food delivery and access to home care. Presence or not of a shortage in food, medication and home care ( binary question)

psychological fraility3 months

Anxiety verbal analogic scale, score from 0= no anxiety to 10= extremly anxious

Secondary Outcome Measures
NameTimeMethod
Caregiver burden3 months

Based on Zarit scale, score from 0= no burden to 16= high caregiver burden

Trial Locations

Locations (1)

CRIUGM

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath